by European Public Health Alliance | Aug 18, 2021 | Consultation Responses, Opinion
Last month, EPHA responded to the European Commission’s public consultation on the creation of a European Health Data Space (EHDS) based on inputs received by our members. Generally speaking, the diversity of our membership is reflected in their engagement with...
by European Public Health Alliance | Aug 16, 2021 | Opinion
This editorial first appeared in the European Journal of Public Health and is reproduced here with their kind permission. Authors: Milka Sokolović, Director-General, EPHA; Dineke Zeegers Paget, Executive Director, European Public Health Association With the call from...
by European Public Health Alliance | Jul 22, 2021 | Opinion
Children represent 20% of the EU’s population, yet, even before the pandemic, almost 18 million children were experiencing poverty and social exclusion. Very young children are often overlooked, despite overwhelming evidence of the benefits of a healthy, safe and...
by European Public Health Alliance | Jul 8, 2021 | Opinion
The access to medicines debate in Europe is at a critical juncture. With the pandemic, all issues, old and new, suddenly find a place on the agenda. They range from the prices of medicines, the flexibility of regulatory standards, the quality of innovation, all the...
by European Public Health Alliance | Jul 8, 2021 | Opinion
Undeniably, pharmaceutical companies’ power and influence have grown in the context of the current pandemic. The politicisation of pharmaceuticals is unprecedented. Pharma CEOs pick up the phone and talk directly to EU heads of state and governments. Companies are...
by European Public Health Alliance | Jul 8, 2021 | Opinion
Guest article: Ella Weggen & Marianne Meijer, Global Health Advovates, Wemos TRIPS waiver, C-TAP, the use of compulsory licensing, donations through COVAX – various strategies have been proposed to increase global access to COVID-19 vaccines. One way or another,...
